Atlas Trials

Treatment of ITP With Rituximab and / or Accutane

Clinical trial NCT02757196 · UNKNOWN

Trial details

NCT number
NCT02757196
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2016-05-01
Primary completion
2017-12-01
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.